Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Inflamm Bowel Dis

Search In Journal Title:

Abbravation: Inflammatory Bowel Diseases

Search In Journal Abbravation:

Publisher

Narnia

Search In Publisher:

DOI

10.1007/978-94-007-0719-1_10

Search In DOI:

ISSN

1078-0998

Search In ISSN:
Search In Title Of Papers:

Role of the interleukin 24 in patients with ulcera

Authors: Camarillo Gabriela Fonseca FuruzawaCarballeda Janette MartínezBenítez Braulio BarretoZúñiga Rafael YamamotoFurusho Jesús K
Publish Date: 2011/10/01
Volume: 17, Issue: 10, Pages: 2209-2210
PDF Link

Abstract

Gabriela Fonseca Camarillo Janette FuruzawaCarballeda Braulio MartínezBenítez Rafael BarretoZúñiga Jesús K YamamotoFurusho Role of the interleukin 24 in patients with ulcerative colitis Inflammatory Bowel Diseases Volume 17 Issue 10 1 October 2011 Pages 2209–2210 https//doiorg/101002/ibd21635Interleukin 24 IL24 is a member of the IL10 family of cytokines together with IL19 IL20 IL22 IL26 IL28 and IL29 IL24 was originally identified as a tumor suppressor molecule melanoma differentiationassociated gene 7 IL24 shares amino acid homology between 20 and 30 with IL10 IL20 and IL221The human IL24 has been reported to induce the expression of proinflammatory cytokines such as tumor necrosis factor alpha TNFα and IL6 in monocytes2 In vivo IL24 is predominantly expressed by skin tissue cells during inflammatory conditions such as psoriasis3 IL24 acts on colonic epithelial cells to elicit JAK1/STAT3 activation and the expression of mucins supporting its suppressive effects on mucosal inflammation in inflammatory bowel disease IBD4

Keywords:

References

citation journal title=J Immunol citation year=2009 citation volume=183 citation pages=687695

.
Search In Abstract Of Papers:
Other Papers In This Journal:
  1. Gender and Location of CRC in IBDImplications for Surveillance Protocols
  2. Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent
  3. Targeting TNF in Postoperative Recurrence of Crohn's Disease:Can We Extinguish the Fire Before It Starts?
  4. Gene Expression Profiling Identifies Mechanisms of Protection to Recurrent Trinitrobenzene Sulfonic Acid Colitis Mediated by Probiotics
  5. Adalimumab Therapy in Crohn's Disease of the Ileal Pouch
  6. Observations on Severity and Activity Indices in a Therapeutic Trial of Active Crohn's Disease
  7. Splenic function and IgM-memory B cells in Crohn's disease patients treated with infliximab
  8. One-year Investigator-blind Randomized Multicenter Trial Comparing Asacol 2.4 g Once Daily with 800 mg Three Times Daily for Maintenance of Remission in Ulcerative Colitis
  9. Role of diet in the development of inflammatory bowel disease
  10. Thromboembolism in pediatric inflammatory bowel disease: Systematic review
  11. Potential Oncogenic Properties of Mobilized Stem Cells in a Subpopulation of Inflammatory Bowel Disease Patients Infected with Helicobacter pylori
  12. Potential Oncogenic Properties of Mobilized Stem Cells in a Subpopulation of Inflammatory Bowel Disease Patients Infected with Helicobacter pylori
  13. Twin Studies Reveal Specific Imbalances in the Mucosaassociated Microbiota of Patients with Ileal Crohn's Disease
  14. Microbial Causation of the Chronic Idiopathic Inflammatory Bowel Diseases
  15. Babesiosis in a Patient on Infliximab for Crohn's Disease
  16. Plasma Chromogranin A in Patients With Inflammatory Bowel Disease: A Possible Explanation
  17. Effect of Adalimumab on Clinical Laboratory Parameters in Patients with Crohn's Disease: Results from the CHARM Trial
  18. Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease
  19. What is the incidence, prevalence, and natural history of indeterminate colitis?
  20. Anti-tumor Necrosis Factor and Postoperative Complications in Crohn's Disease: Systematic Review and Meta-analysis
  21. Effects of T cell-induced colonic inflammation on epithelial barrier function†
  22. Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients
  23. Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine a in patients with steroid resistant ulcerative colitis
  24. Dangers associated with endoscopic management of strictures in IBD
  25. Combination of innate and adaptive immune alterations increased the likelihood of fibrostenosis in Crohn's disease†
  26. Antibodies Against Cyclic Citrullinated Peptide (CCP) in Inflammatory Bowel Disease Patients With or Without Arthritic Manifestations
  27. Nitric Oxide and Colitis: Rats, Humans and Now Macaques
  28. Distinct Microbiome in Pouchitis Compared to Healthy Pouches in Ulcerative Colitis and Familial Adenomatous Polyposis
  29. Is Crohn's creeping fat an adipose tissue?
  30. Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease
  31. Cyclosporine in the management of severe ulcerative colitis while breast-feeding
  32. Nailing down the shingles in IBD
  33. Local Injection of Infliximab in Symptomatic Isolated Mucosal LesionsA Novel Scenario for Endoscopic Therapy?
  34. A New Type of Strictureplasty for the Treatment of Multiple Long Stenosis in Crohn's Disease
Search Result: